Pages that link to "Q37696603"
Jump to navigation
Jump to search
The following pages link to Hepatitis C therapy with interferon-α and ribavirin reduces CD4 T-cell-associated HIV-1 DNA in HIV-1/hepatitis C virus-coinfected patients (Q37696603):
Displaying 36 items.
- Interferon-alpha, immune activation and immune dysfunction in treated HIV infection (Q26861003) (← links)
- Ongoing Clinical Trials of Human Immunodeficiency Virus Latency-Reversing and Immunomodulatory Agents (Q28079455) (← links)
- Tetherin/BST-2: Restriction Factor or Immunomodulator? (Q30385433) (← links)
- HIV-1 and interferons: who's interfering with whom? (Q34473801) (← links)
- Short communication: Nitazoxanide inhibits HIV viral replication in monocyte-derived macrophages (Q35036587) (← links)
- Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo (Q35295003) (← links)
- Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification (Q35823060) (← links)
- Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms (Q35830651) (← links)
- Innate Immune Activity Correlates with CD4 T Cell-Associated HIV-1 DNA Decline during Latency-Reversing Treatment with Panobinostat (Q36086345) (← links)
- Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4 T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy (Q36597778) (← links)
- Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir? (Q36827134) (← links)
- Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs (Q37545050) (← links)
- Type I interferon: understanding its role in HIV pathogenesis and therapy (Q38348388) (← links)
- Peginterferon α-2a for the treatment of HIV infection (Q38669306) (← links)
- Time course of cellular HIV-DNA and low-level HIV viremia in HIV-HCV co-infected patients whose HCV infection had been successfully treated with directly acting antivirals (Q40060728) (← links)
- The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon. (Q40098403) (← links)
- Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection (Q40280217) (← links)
- Gene therapy with plasmids encoding IFN-β or IFN-α14 confers long-term resistance to HIV-1 in humanized mice (Q40510052) (← links)
- The evolving role of interferons in viral eradication strategies (Q40591698) (← links)
- Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo (Q40705563) (← links)
- Vpr Promotes Macrophage-Dependent HIV-1 Infection of CD4 T Lymphocytes (Q41102793) (← links)
- Control of HIV infection by IFN-α: implications for latency and a cure (Q41922021) (← links)
- Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals (Q44537545) (← links)
- The Significance of Type-I Interferons in the Pathogenesis and Therapy of Human Immunodeficiency Virus 1 Infection (Q45324456) (← links)
- Pegylated IFN-α-induced NK cell activation is associated with HIV-1 DNA decline in ART-treated HIV-1/HCV co-infected patients. (Q47258805) (← links)
- Short-term pIFN-α2a treatment does not significantly reduce the viral reservoir of SIV-infected, ART-treated rhesus macaques. (Q54222562) (← links)
- Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure. (Q55153874) (← links)
- Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies. (Q55260301) (← links)
- HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study (Q64082687) (← links)
- Dose-Dependent Differences in HIV Inhibition by Different Interferon Alpha Subtypes While Having Overall Similar Biologic Effects (Q64241515) (← links)
- Diverse effects of interferon alpha on the establishment and reversal of HIV latency (Q89935915) (← links)
- Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART (Q92034495) (← links)
- Human Dendritic Cell Subsets, Ontogeny, and Impact on HIV Infection (Q92479178) (← links)
- Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell Responses (Q92859937) (← links)
- Hepatitis C Virus (HCV) Clearance After Treatment With Direct-Acting Antivirals in Human Immunodeficiency Virus (HIV)-HCV Coinfection Modulates Systemic Immune Activation and HIV Transcription on Antiretroviral Therapy (Q94547628) (← links)
- Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis (Q100678665) (← links)